Abstract:The listing of authors was incorrect in the published version. The correct author names and affiliations appear as above. The authors would like to include the following acknowledgments: We wish to thank Prof. K. Fukunaga (Tohoku University) for generously providing the antibodies (Nitrotyrosine, HtrA2, Fas, Fas ligand and TNFa). We also thank Dr. S. Moriguchi and N. Shioda (Tohoku University) for helpful comments and constructive discussion on the manuscript. Thisworkwas supported in part byNational Natural Science Foundations of China (30672564 to Y. Lou; 30973521 to F. Han), The Science Research Foundation of Chinese Ministry of Health (WKJ2009-2-029 to F. Han), The Key Foundation of Zhejiang Educational Committee (Z200803527 to F. Han) and by the Key Foundation of Modernization of Chinese Traditional Medicine of Zhejiang Province (2006C13075 to Y. Lou). The authors would like to apologize for any inconvenience caused.

Erratum To: Targeting Apoptosis for Optical Imaging of Infection

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum

Erratum: Excretable IR-820 for in vivo NIR-II fluorescence cerebrovascular imaging and photothermal therapy of subcutaneous tumor: Erratum.

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Targeting Apoptosis for Optical Imaging of Infection

Erratum: Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum.

Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Adaptive Optics Fluorescence Lifetime Imaging Ophthalmoscopy of in Vivo Human Retinal Pigment Epithelium: Erratum

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Correction: Corrigendum: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Erratum to “Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease”

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Correction To: Novel Smac Mimetic APG-1387 Elicits Ovarian Cancer Cell Killing Through TNF-alpha, Ripoptosome and Autophagy Mediated Cell Death Pathway

Correction To: Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells: the Effect of Combining RNA Interference with Tyrosine Kinase Inhibitors or Cetuximab

Correction To: SPECT/CT Imaging of Apoptosis in Aortic Aneurysm with Radiolabeled Duramycin

Correction: A Mitochondria-Targeted Dual-Functional Aggregation-Induced Emission Luminogen for Intracellular Mitochondrial Imaging and Photodynamic Therapy

Berichtigung: A Nanoscale Metal–Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy

Correction to: Fluorescence Imaging-Guided Identification of Thymic Masses Using Low-Dose Indocyanine Green

Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]